Published in Psychopharmacology (Berl) on March 16, 2010
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacol Rev (2011) 1.26
Animal models of serotonergic psychedelics. ACS Chem Neurosci (2012) 1.03
Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol Behav (2011) 0.94
Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits? Neuropharmacology (2011) 0.88
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.87
Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains. Neuropharmacology (2011) 0.78
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A (2002) 4.34
Psychotomimesis mediated by kappa opiate receptors. Science (1986) 3.60
The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci (2008) 3.54
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A (1992) 3.02
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther (2005) 2.66
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res (2009) 2.61
Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther (2007) 2.51
Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A (2006) 2.29
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther (2007) 2.06
How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull (2007) 1.87
Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology (2006) 1.81
Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) (1988) 1.80
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) (2008) 1.68
Startle modulation in children with posttraumatic stress disorder. Am J Psychiatry (1989) 1.67
Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J Neurosci (2005) 1.56
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci (2001) 1.54
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther (1992) 1.51
Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex (2007) 1.49
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry (2003) 1.48
Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci (2000) 1.44
Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res (1996) 1.43
Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther (2009) 1.42
Examining the intersection of sex and stress in modelling neuropsychiatric disorders. J Neuroendocrinol (2009) 1.32
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry (2003) 1.28
Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci (2004) 1.26
Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci (2000) 1.24
Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther (1994) 1.23
Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals. Neurosci Biobehav Rev (2008) 1.21
The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox Res (2006) 1.15
Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci (1999) 1.10
Rat sex and strain differences in responses to stress. Physiol Behav (2002) 1.09
Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci (2003) 1.06
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology (2006) 1.01
Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience (1996) 1.00
Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology (Berl) (1994) 0.99
Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory. J Neurosci (2009) 0.99
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther (1991) 0.99
Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res (2008) 0.98
Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology (2007) 0.96
Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats. Neuroscience (2005) 0.96
Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behav Pharmacol (2008) 0.95
Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience (1998) 0.95
Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex. Brain Res (2002) 0.94
Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology (Berl) (2002) 0.94
Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur J Neurosci (1994) 0.94
Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Pharmacol Biochem Behav (2007) 0.92
Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats. Biol Psychiatry (2005) 0.92
Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl) (1993) 0.92
Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.91
Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci (2005) 0.91
Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience (1996) 0.90
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther (1998) 0.90
Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. Eur J Neurosci (2006) 0.90
Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse (1998) 0.90
Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology (2003) 0.89
Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Mol Psychiatry (2002) 0.88
Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.88
CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biol Psychiatry (2007) 0.88
Social defeat stress produces prolonged alterations in acoustic startle and body weight gain in male Long Evans rats. J Psychiatr Res (2009) 0.87
Toxic psychosis after intake of the hallucinogen salvinorin A. J Clin Psychiatry (2008) 0.86
Difference in anxiety and sensitization of the acoustic startle response between the two inbred mouse strains BALB/cAN and DBA/2N. Genes Brain Behav (2002) 0.86
Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice. Neurobiol Learn Mem (2007) 0.85
Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion. Schizophr Res (2009) 0.85
Effects of cold stress on early and late stimulus gating. Psychiatry Res (2005) 0.83
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients. Psychiatry Res (1990) 0.82
Microinjection of dynorphin into the hippocampus impairs spatial learning in rats. Pharmacol Biochem Behav (1990) 0.82
Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.82
The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav (2008) 0.82
Do cognitive deficits in juvenile bipolar disorder persist into adulthood? J Nerv Ment Dis (2007) 0.81
Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacol Biochem Behav (2007) 0.81
The disruptive effect of cocaine on prepulse inhibition is prevented by repeated administration in rats. Neuropsychopharmacology (2000) 0.80
Behavioral effects Of 8-OH-DPAT in chronically stressed male and female rats. Pharmacol Biochem Behav (2000) 0.79
Multisensory deficits in rats produced by acute exposure to cold swim stress. Behav Neurosci (1989) 0.78
The price of seizure control: dynorphins in interictal and postictal psychosis. Psychiatry Res (2007) 0.78
Cellular distribution of the mRNA for the kappa-opioid receptor in the human neocortex: a non-isotopic in situ hybridization study. Neurosci Lett (1995) 0.77
Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats. Psychopharmacology (Berl) (2008) 0.76
Alterations in other sensory modalities accompanying stress analgesia as measured by startle reflex modification. Ann N Y Acad Sci (1986) 0.76
Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development. Immunity (2006) 3.62
Origins and unconventional behavior of neutrophils in developing zebrafish. Blood (2007) 2.76
Live imaging of emerging hematopoietic stem cells and early thymus colonization. Blood (2007) 2.36
Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. J Neurosci (2010) 2.33
Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A (2006) 2.29
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol (2007) 2.28
PI 3-kinase regulation of dopamine uptake. J Neurochem (2002) 1.64
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci (2003) 1.63
Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci U S A (2002) 1.55
Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun (2002) 1.49
Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet (2003) 1.40
Neural systems underlying opiate addiction. J Neurosci (2002) 1.33
Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther (2010) 1.30
Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiol Dis (2007) 1.24
Network of coregulated spliceosome components revealed by zebrafish mutant in recycling factor p110. Proc Natl Acad Sci U S A (2007) 1.24
Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6J and DBA/2J mice. Neuropsychopharmacology (2006) 1.21
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J (2011) 1.19
Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem (2007) 1.19
Pathobiology of dynorphins in trauma and disease. Front Biosci (2005) 1.17
Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry (2008) 1.10
Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. J Neurosci (2003) 1.08
Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice. Eur J Neurosci (2003) 1.07
Evolution and development of immunological structures in the lamprey. Curr Opin Immunol (2007) 1.06
Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. J Neurosci Methods (2006) 1.05
Overview of brain microdialysis. Curr Protoc Neurosci (2009) 1.05
Zebrafish mutants with disrupted early T-cell and thymus development identified in early pressure screen. Dev Dyn (2008) 1.04
Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology (2006) 1.04
Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion. Neuropsychopharmacology (2013) 1.04
Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology (Berl) (2008) 1.03
Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One (2009) 1.00
Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. Stem Cells Dev (2010) 1.00
The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology (2007) 0.99
NMDA receptors on non-dopaminergic neurons in the VTA support cocaine sensitization. PLoS One (2010) 0.99
Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology (2013) 0.99
Endogenous kappa opioid receptor systems modulate the responsiveness of mesoaccumbal dopamine neurons to ethanol. Alcohol Clin Exp Res (2006) 0.96
The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes. J Pharmacol Exp Ther (2010) 0.96
Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology (2007) 0.95
Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. Eur J Neurosci (2003) 0.95
Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nat Neurosci (2011) 0.93
NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology (2002) 0.93
Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system. J Neurosci (2010) 0.91
5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats. Neuropsychopharmacology (2007) 0.90
Pharmacological and genetic manipulation of kappa opioid receptors: effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling. Neuropharmacology (2006) 0.88
Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+. J Neurochem (2010) 0.86
The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. J Neurochem (2009) 0.85
Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes (2012) 0.84
Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures. Neurosci Lett (2005) 0.84
The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. J Pharmacol Exp Ther (2007) 0.83
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res (2009) 0.82
Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology (2005) 0.82
Basolateral amygdala-driven augmentation of medial prefrontal cortex GABAergic neurotransmission in response to environmental stimuli associated with cocaine administration. Neuropsychopharmacology (2011) 0.82
The effects of local perfusion of DAMGO on extracellular GABA and glutamate concentrations in the rostral ventromedial medulla. J Neurochem (2007) 0.81
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. J Biol Chem (2011) 0.81
Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function. Mol Pharmacol (2011) 0.78
Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons. J Neurophysiol (2007) 0.78
Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. Neurochem Res (2010) 0.77
Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla. J Neurosci (2012) 0.77
Eph/Ephrin-mediated interactions in the thymus. Neuroimmunomodulation (2011) 0.77
Microdialysis in rodents. Curr Protoc Neurosci (2009) 0.77
Methylene blue inhibits function of the 5-HT transporter. Br J Pharmacol (2012) 0.75
Detection and quantification of neurotransmitters in dialysates. Curr Protoc Neurosci (2009) 0.75
Detection and quantification of neurotransmitters in dialysates. Curr Protoc Neurosci (2013) 0.75